This study demonstrates that FVTF substantially decreased in vitro and in vivo stemness of HCC cells through the downregulation of DNMT1, indicating that FVTF may be a promising anti-cancer agent via targeting DNMT1. The gene discussed is DNMT1; the disease is cancer.